SJ, W., CN, L., Y, T., H, J., H, F., YR, Z., . . . C, H. (2026). Methodological and reporting rigor in noninferiority and equivalence trials for multimodality cancer treatment: Lessons from breast cancer radiotherapy. Journal of clinical epidemiology, 189, 112012. https://doi.org/10.1016/j.jclinepi.2025.112012
Chicago Style (17th ed.) CitationSJ, Wang, et al. "Methodological and Reporting Rigor in Noninferiority and Equivalence Trials for Multimodality Cancer Treatment: Lessons from Breast Cancer Radiotherapy." Journal of Clinical Epidemiology 189 (2026): 112012. https://doi.org/10.1016/j.jclinepi.2025.112012.
MLA (9th ed.) CitationSJ, Wang, et al. "Methodological and Reporting Rigor in Noninferiority and Equivalence Trials for Multimodality Cancer Treatment: Lessons from Breast Cancer Radiotherapy." Journal of Clinical Epidemiology, vol. 189, 2026, p. 112012, https://doi.org/10.1016/j.jclinepi.2025.112012.